The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Polio Vaccines (OPV) Market Research Report 2024
Synopsis
The global Oral Polio Vaccines (OPV) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Polio Vaccines (OPV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Polio Vaccines (OPV).
Report Scope
The Oral Polio Vaccines (OPV) market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Polio Vaccines (OPV) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Polio Vaccines (OPV) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Trivalent OPV
Bivalent OPV
Segment by Application
Public
Private
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Polio Vaccines (OPV) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Polio Vaccines (OPV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Oral Polio Vaccines (OPV) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Polio Vaccines (OPV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Polio Vaccines (OPV).
Report Scope
The Oral Polio Vaccines (OPV) market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Polio Vaccines (OPV) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Polio Vaccines (OPV) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Trivalent OPV
Bivalent OPV
Segment by Application
Public
Private
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Polio Vaccines (OPV) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Polio Vaccines (OPV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oral Polio Vaccines (OPV) Market Overview
1.1 Product Overview and Scope of Oral Polio Vaccines (OPV)
1.2 Oral Polio Vaccines (OPV) Segment by Type
1.2.1 Global Oral Polio Vaccines (OPV) Market Value Comparison by Type (2024-2030)
1.2.2 Trivalent OPV
1.2.3 Bivalent OPV
1.3 Oral Polio Vaccines (OPV) Segment by Application
1.3.1 Global Oral Polio Vaccines (OPV) Market Value by Application: (2024-2030)
1.3.2 Public
1.3.3 Private
1.4 Global Oral Polio Vaccines (OPV) Market Size Estimates and Forecasts
1.4.1 Global Oral Polio Vaccines (OPV) Revenue 2019-2030
1.4.2 Global Oral Polio Vaccines (OPV) Sales 2019-2030
1.4.3 Global Oral Polio Vaccines (OPV) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Polio Vaccines (OPV) Market Competition by Manufacturers
2.1 Global Oral Polio Vaccines (OPV) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Polio Vaccines (OPV) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Polio Vaccines (OPV) Average Price by Manufacturers (2019-2024)
2.4 Global Oral Polio Vaccines (OPV) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Polio Vaccines (OPV), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Polio Vaccines (OPV), Product Type & Application
2.7 Oral Polio Vaccines (OPV) Market Competitive Situation and Trends
2.7.1 Oral Polio Vaccines (OPV) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Polio Vaccines (OPV) Players Market Share by Revenue
2.7.3 Global Oral Polio Vaccines (OPV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Polio Vaccines (OPV) Retrospective Market Scenario by Region
3.1 Global Oral Polio Vaccines (OPV) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Polio Vaccines (OPV) Global Oral Polio Vaccines (OPV) Sales by Region: 2019-2030
3.2.1 Global Oral Polio Vaccines (OPV) Sales by Region: 2019-2024
3.2.2 Global Oral Polio Vaccines (OPV) Sales by Region: 2025-2030
3.3 Global Oral Polio Vaccines (OPV) Global Oral Polio Vaccines (OPV) Revenue by Region: 2019-2030
3.3.1 Global Oral Polio Vaccines (OPV) Revenue by Region: 2019-2024
3.3.2 Global Oral Polio Vaccines (OPV) Revenue by Region: 2025-2030
3.4 North America Oral Polio Vaccines (OPV) Market Facts & Figures by Country
3.4.1 North America Oral Polio Vaccines (OPV) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Polio Vaccines (OPV) Sales by Country (2019-2030)
3.4.3 North America Oral Polio Vaccines (OPV) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Polio Vaccines (OPV) Market Facts & Figures by Country
3.5.1 Europe Oral Polio Vaccines (OPV) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Polio Vaccines (OPV) Sales by Country (2019-2030)
3.5.3 Europe Oral Polio Vaccines (OPV) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Polio Vaccines (OPV) Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Polio Vaccines (OPV) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Polio Vaccines (OPV) Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Polio Vaccines (OPV) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Polio Vaccines (OPV) Market Facts & Figures by Country
3.7.1 Latin America Oral Polio Vaccines (OPV) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Polio Vaccines (OPV) Sales by Country (2019-2030)
3.7.3 Latin America Oral Polio Vaccines (OPV) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Polio Vaccines (OPV) Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Polio Vaccines (OPV) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oral Polio Vaccines (OPV) Sales by Type (2019-2030)
4.1.1 Global Oral Polio Vaccines (OPV) Sales by Type (2019-2024)
4.1.2 Global Oral Polio Vaccines (OPV) Sales by Type (2025-2030)
4.1.3 Global Oral Polio Vaccines (OPV) Sales Market Share by Type (2019-2030)
4.2 Global Oral Polio Vaccines (OPV) Revenue by Type (2019-2030)
4.2.1 Global Oral Polio Vaccines (OPV) Revenue by Type (2019-2024)
4.2.2 Global Oral Polio Vaccines (OPV) Revenue by Type (2025-2030)
4.2.3 Global Oral Polio Vaccines (OPV) Revenue Market Share by Type (2019-2030)
4.3 Global Oral Polio Vaccines (OPV) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Polio Vaccines (OPV) Sales by Application (2019-2030)
5.1.1 Global Oral Polio Vaccines (OPV) Sales by Application (2019-2024)
5.1.2 Global Oral Polio Vaccines (OPV) Sales by Application (2025-2030)
5.1.3 Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2019-2030)
5.2 Global Oral Polio Vaccines (OPV) Revenue by Application (2019-2030)
5.2.1 Global Oral Polio Vaccines (OPV) Revenue by Application (2019-2024)
5.2.2 Global Oral Polio Vaccines (OPV) Revenue by Application (2025-2030)
5.2.3 Global Oral Polio Vaccines (OPV) Revenue Market Share by Application (2019-2030)
5.3 Global Oral Polio Vaccines (OPV) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Oral Polio Vaccines (OPV) Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Oral Polio Vaccines (OPV) Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Corporation Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bibcol Oral Polio Vaccines (OPV) Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Corporation Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute Oral Polio Vaccines (OPV) Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Corporation Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tiantan Biological Oral Polio Vaccines (OPV) Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 Panacea Biotec Ltd
6.6.1 Panacea Biotec Ltd Corporation Information
6.6.2 Panacea Biotec Ltd Description and Business Overview
6.6.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product Portfolio
6.6.5 Panacea Biotec Ltd Recent Developments/Updates
6.7 Bio-Med
6.6.1 Bio-Med Corporation Information
6.6.2 Bio-Med Description and Business Overview
6.6.3 Bio-Med Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bio-Med Oral Polio Vaccines (OPV) Product Portfolio
6.7.5 Bio-Med Recent Developments/Updates
6.8 Halfkin Bio-Pharmaceuticals
6.8.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.8.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.8.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product Portfolio
6.8.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Polio Vaccines (OPV) Industry Chain Analysis
7.2 Oral Polio Vaccines (OPV) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Polio Vaccines (OPV) Production Mode & Process
7.4 Oral Polio Vaccines (OPV) Sales and Marketing
7.4.1 Oral Polio Vaccines (OPV) Sales Channels
7.4.2 Oral Polio Vaccines (OPV) Distributors
7.5 Oral Polio Vaccines (OPV) Customers
8 Oral Polio Vaccines (OPV) Market Dynamics
8.1 Oral Polio Vaccines (OPV) Industry Trends
8.2 Oral Polio Vaccines (OPV) Market Drivers
8.3 Oral Polio Vaccines (OPV) Market Challenges
8.4 Oral Polio Vaccines (OPV) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Oral Polio Vaccines (OPV) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Oral Polio Vaccines (OPV) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Oral Polio Vaccines (OPV) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Oral Polio Vaccines (OPV) Sales (M Doses) of Key Manufacturers (2019-2024)
Table 5. Global Oral Polio Vaccines (OPV) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Oral Polio Vaccines (OPV) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Oral Polio Vaccines (OPV) Average Price (USD/Doses) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Oral Polio Vaccines (OPV), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Polio Vaccines (OPV), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Polio Vaccines (OPV), Product Type & Application
Table 12. Global Key Manufacturers of Oral Polio Vaccines (OPV), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Polio Vaccines (OPV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Polio Vaccines (OPV) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Polio Vaccines (OPV) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Oral Polio Vaccines (OPV) Sales by Region (2019-2024) & (M Doses)
Table 18. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2019-2024)
Table 19. Global Oral Polio Vaccines (OPV) Sales by Region (2025-2030) & (M Doses)
Table 20. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2025-2030)
Table 21. Global Oral Polio Vaccines (OPV) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Oral Polio Vaccines (OPV) Revenue Market Share by Region (2019-2024)
Table 23. Global Oral Polio Vaccines (OPV) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Oral Polio Vaccines (OPV) Revenue Market Share by Region (2025-2030)
Table 25. North America Oral Polio Vaccines (OPV) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Oral Polio Vaccines (OPV) Sales by Country (2019-2024) & (M Doses)
Table 27. North America Oral Polio Vaccines (OPV) Sales by Country (2025-2030) & (M Doses)
Table 28. North America Oral Polio Vaccines (OPV) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Oral Polio Vaccines (OPV) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Oral Polio Vaccines (OPV) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Oral Polio Vaccines (OPV) Sales by Country (2019-2024) & (M Doses)
Table 32. Europe Oral Polio Vaccines (OPV) Sales by Country (2025-2030) & (M Doses)
Table 33. Europe Oral Polio Vaccines (OPV) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Oral Polio Vaccines (OPV) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Oral Polio Vaccines (OPV) Sales by Region (2019-2024) & (M Doses)
Table 37. Asia Pacific Oral Polio Vaccines (OPV) Sales by Region (2025-2030) & (M Doses)
Table 38. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oral Polio Vaccines (OPV) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Oral Polio Vaccines (OPV) Sales by Country (2019-2024) & (M Doses)
Table 42. Latin America Oral Polio Vaccines (OPV) Sales by Country (2025-2030) & (M Doses)
Table 43. Latin America Oral Polio Vaccines (OPV) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oral Polio Vaccines (OPV) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Oral Polio Vaccines (OPV) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Oral Polio Vaccines (OPV) Sales by Country (2019-2024) & (M Doses)
Table 47. Middle East & Africa Oral Polio Vaccines (OPV) Sales by Country (2025-2030) & (M Doses)
Table 48. Middle East & Africa Oral Polio Vaccines (OPV) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Oral Polio Vaccines (OPV) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Oral Polio Vaccines (OPV) Sales (M Doses) by Type (2019-2024)
Table 51. Global Oral Polio Vaccines (OPV) Sales (M Doses) by Type (2025-2030)
Table 52. Global Oral Polio Vaccines (OPV) Sales Market Share by Type (2019-2024)
Table 53. Global Oral Polio Vaccines (OPV) Sales Market Share by Type (2025-2030)
Table 54. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Oral Polio Vaccines (OPV) Revenue Market Share by Type (2019-2024)
Table 57. Global Oral Polio Vaccines (OPV) Revenue Market Share by Type (2025-2030)
Table 58. Global Oral Polio Vaccines (OPV) Price (USD/Doses) by Type (2019-2024)
Table 59. Global Oral Polio Vaccines (OPV) Price (USD/Doses) by Type (2025-2030)
Table 60. Global Oral Polio Vaccines (OPV) Sales (M Doses) by Application (2019-2024)
Table 61. Global Oral Polio Vaccines (OPV) Sales (M Doses) by Application (2025-2030)
Table 62. Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2019-2024)
Table 63. Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2025-2030)
Table 64. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Oral Polio Vaccines (OPV) Revenue Market Share by Application (2019-2024)
Table 67. Global Oral Polio Vaccines (OPV) Revenue Market Share by Application (2025-2030)
Table 68. Global Oral Polio Vaccines (OPV) Price (USD/Doses) by Application (2019-2024)
Table 69. Global Oral Polio Vaccines (OPV) Price (USD/Doses) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 73. Sanofi Oral Polio Vaccines (OPV) Product
Table 74. Sanofi Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 78. GSK Oral Polio Vaccines (OPV) Product
Table 79. GSK Recent Developments/Updates
Table 80. Bibcol Corporation Information
Table 81. Bibcol Description and Business Overview
Table 82. Bibcol Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 83. Bibcol Oral Polio Vaccines (OPV) Product
Table 84. Bibcol Recent Developments/Updates
Table 85. Serum Institute Corporation Information
Table 86. Serum Institute Description and Business Overview
Table 87. Serum Institute Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 88. Serum Institute Oral Polio Vaccines (OPV) Product
Table 89. Serum Institute Recent Developments/Updates
Table 90. Tiantan Biological Corporation Information
Table 91. Tiantan Biological Description and Business Overview
Table 92. Tiantan Biological Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 93. Tiantan Biological Oral Polio Vaccines (OPV) Product
Table 94. Tiantan Biological Recent Developments/Updates
Table 95. Panacea Biotec Ltd Corporation Information
Table 96. Panacea Biotec Ltd Description and Business Overview
Table 97. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 98. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product
Table 99. Panacea Biotec Ltd Recent Developments/Updates
Table 100. Bio-Med Corporation Information
Table 101. Bio-Med Description and Business Overview
Table 102. Bio-Med Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 103. Bio-Med Oral Polio Vaccines (OPV) Product
Table 104. Bio-Med Recent Developments/Updates
Table 105. Halfkin Bio-Pharmaceuticals Corporation Information
Table 106. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 107. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 108. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product
Table 109. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Oral Polio Vaccines (OPV) Distributors List
Table 113. Oral Polio Vaccines (OPV) Customers List
Table 114. Oral Polio Vaccines (OPV) Market Trends
Table 115. Oral Polio Vaccines (OPV) Market Drivers
Table 116. Oral Polio Vaccines (OPV) Market Challenges
Table 117. Oral Polio Vaccines (OPV) Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Polio Vaccines (OPV)
Figure 2. Global Oral Polio Vaccines (OPV) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Oral Polio Vaccines (OPV) Market Share by Type in 2023 & 2030
Figure 4. Trivalent OPV Product Picture
Figure 5. Bivalent OPV Product Picture
Figure 6. Global Oral Polio Vaccines (OPV) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Oral Polio Vaccines (OPV) Market Share by Application in 2023 & 2030
Figure 8. Public
Figure 9. Private
Figure 10. Global Oral Polio Vaccines (OPV) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Oral Polio Vaccines (OPV) Market Size (2019-2030) & (US$ Million)
Figure 12. Global Oral Polio Vaccines (OPV) Sales (2019-2030) & (M Doses)
Figure 13. Global Oral Polio Vaccines (OPV) Average Price (USD/Doses) & (2019-2030)
Figure 14. Oral Polio Vaccines (OPV) Report Years Considered
Figure 15. Oral Polio Vaccines (OPV) Sales Share by Manufacturers in 2023
Figure 16. Global Oral Polio Vaccines (OPV) Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Oral Polio Vaccines (OPV) Players: Market Share by Revenue in 2023
Figure 18. Oral Polio Vaccines (OPV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Oral Polio Vaccines (OPV) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Oral Polio Vaccines (OPV) Sales Market Share by Country (2019-2030)
Figure 21. North America Oral Polio Vaccines (OPV) Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Oral Polio Vaccines (OPV) Sales Market Share by Country (2019-2030)
Figure 25. Europe Oral Polio Vaccines (OPV) Revenue Market Share by Country (2019-2030)
Figure 26. Germany Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Oral Polio Vaccines (OPV) Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Oral Polio Vaccines (OPV) Revenue Market Share by Region (2019-2030)
Figure 33. China Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Oral Polio Vaccines (OPV) Sales Market Share by Country (2019-2030)
Figure 44. Latin America Oral Polio Vaccines (OPV) Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Oral Polio Vaccines (OPV) Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Oral Polio Vaccines (OPV) Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Oral Polio Vaccines (OPV) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Oral Polio Vaccines (OPV) by Type (2019-2030)
Figure 54. Global Revenue Market Share of Oral Polio Vaccines (OPV) by Type (2019-2030)
Figure 55. Global Oral Polio Vaccines (OPV) Price (USD/Doses) by Type (2019-2030)
Figure 56. Global Sales Market Share of Oral Polio Vaccines (OPV) by Application (2019-2030)
Figure 57. Global Revenue Market Share of Oral Polio Vaccines (OPV) by Application (2019-2030)
Figure 58. Global Oral Polio Vaccines (OPV) Price (USD/Doses) by Application (2019-2030)
Figure 59. Oral Polio Vaccines (OPV) Value Chain
Figure 60. Oral Polio Vaccines (OPV) Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
